Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune system modulation via T cell and NK cell activation is a complex process involving the recognition of antigens or stress ligands, co-stimulatory and inhibitory signals, and cytokine production. T cell activation requires antigen presentation via MHC molecules and co-stimulation through CD28/B7 interaction. NK cell activation is regulated by a balance between activating and inhibitory receptors. Therapeutic modulation of these pathways is relevant in cancer immunotherapy and autoimmune disease management.
Modulation of T cell receptor signaling, co-stimulation, co-inhibition, and NK cell receptor activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Modulation via T Cell and NK Cell Activation (N/A).